State University of New York - Upstate Medical University
upstate.eduLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
155
Active
11
Phase 3
4
Total enrollment
11,854
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| N-acetylcysteine | — | — | — | — | — | 1 | |
| Sirolimus | — | — | — | — | — | 1 | |
| Tafenoquine Oral | — | — | — | — | — | 1 | |
| Ceftriaxone | — | — | — | — | — | 1 | |
| Dextrose 5% | — | — | — | — | — | 1 | |
| Activated Charcoal | — | — | — | — | 2 |
Next readouts
- 2026-05-01
- 2026-12
- 2027-03
- 2027-03-31
- 2029-01-01
Top conditions
- Obesity4
- Autism Spectrum Disorder4
- Borderline Personality Disorder4
- Schizophrenia4
- Alcohol Dependence4
- Osteoporosis3
- Dengue3
- Pain3
Frequently asked questions about State University of New York - Upstate Medical University
- How many clinical trials does State University of New York - Upstate Medical University have on ClinicalTrials.gov?
- State University of New York - Upstate Medical University is listed as the lead sponsor on 155 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of State University of New York - Upstate Medical University's trials are in Phase 3?
- 4 of State University of New York - Upstate Medical University's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does State University of New York - Upstate Medical University focus on?
- State University of New York - Upstate Medical University's most-studied conditions on ClinicalTrials.gov are Obesity, Autism Spectrum Disorder, Borderline Personality Disorder, Schizophrenia, Alcohol Dependence.
- When are State University of New York - Upstate Medical University's next clinical trial readouts?
- State University of New York - Upstate Medical University has 5 upcoming primary-completion readouts tracked here; the soonest is “Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay”, expected around 2026-05-01.